Artrya Limited (ASX: AYA) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Artrya Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Artrya Limited (ASX: AYA)
Latest News
Technology Shares
This ASX tech stock is jumping 6% on big US AI news
AI Stocks
Up 752% in one year! This roaring ASX AI stock just hit all-time highs on major revenue milestone
Share Gainers
Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today
AI Stocks
Why is this ASX AI share jumping 11% today?
Small Cap Shares
These 2 ASX small-cap shares have big potential for returns
Share Market News
5 ASX artificial intelligence (AI) shares to watch in 2025
IPOs
New artificial intelligence ASX share rockets 13% on debut
Technology Shares
Move over Appen: A new artificial intelligence stock to list on the ASX
Frequently Asked Questions
-
No, Artrya has not yet paid dividends to shareholders.
-
The company, founded in 2019 in Perth, listed on the ASX on 26 November 2021.
AYA ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Artrya Limited
Artrya Ltd (ASX: AYA) is an AI-driven medical technology company that assists clinicians in the diagnosis of coronary heart disease. Artrya’s Salix Coronary Anatomy is a coronary computed tomography angiography (CCTA) image analysis solution that allows physicians with AI to identify and analyse the extent and type of arterial plaque, and help identify patients at risk of a heart attack.
The Perth-based company says the technology will revolutionise the speed and accuracy of coronary artery disease diagnosis.
